top of page
Developed a new B2B product offering for 23andMe, the leading personal genetics company.
As the largest source of genotypic and phenotypic data in the world, 23andMe is uniquely positioned to shed light on patient insights
for those planning new clinical trials
When developing protocols for clinical trials, it is difficult to assess information about potential patients, such as:
Disease severity and comorbidities
Design a scalable and customizable customer insights dashboard to inform the planning of clinical trials
Pharmaceutical companies and clinical research organizations scoping out new trials
Created two prototypes:
Initial form built to filter 23andMe customer database by key cohort segments
Visually compelling and flexible dashboard to display cohort insights
Created dynamic form to
capture key search parameters.
Designed customizable customer insights dashboard that displays key metrics at a glance.
Dynamically adjust parameters and distributions of:
Proximity to target locations (trial sites)
Created Cohort Explorer concept to allow dashboard users to search 23andMe research questions for custom cohort-relevant insights
The 23andMe Insights platform solves for a key challenge in the clinical trial planning space: trial feasibility.
By creating a platform that easily toggles between cohort demographics and draws from the largest patient insights data source in the world, those planning clinical trials can quickly get a visual pulse on the best way to structure a trial protocol.
bottom of page